Skip to main content

Warfarin

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Genentech
GenentechCA - Oceanside
1 program
1
CoaguChekPhase 41 trial
Active Trials
NCT00594828Unknown163Est. Apr 2008
Bryan Corporation
Bryan CorporationOH - Cincinnati
1 program
Warfarin dosage adjustment modelN/A1 trial
Active Trials
NCT05609500Unknown1,200Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenentechCoaguChek
Bryan CorporationWarfarin dosage adjustment model

Clinical Trials (2)

Total enrollment: 1,363 patients across 2 trials

Patient Self Testing of Warfarin Therapy

Start: Jul 2006Est. completion: Apr 2008163 patients
Phase 4Unknown
NCT05609500Bryan CorporationWarfarin dosage adjustment model

Warfarin Dosage Adjustment Model Analysis Study

Start: Sep 2022Est. completion: Dec 20231,200 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.